# Protection Against Pneumococcal Infection in Children With T1DM

> **NCT01939522** · PHASE4 · COMPLETED · sponsor: **University of Oxford** · enrollment: 50 (actual)

## Conditions studied

- Type 1 Diabetes Mellitus

## Interventions

- **BIOLOGICAL:** 13-valent pneumococcal conjugate vaccine (PCV13)

## Key facts

- **NCT ID:** NCT01939522
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2016-04
- **Final completion:** 2017-01
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2017-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01939522

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01939522, "Protection Against Pneumococcal Infection in Children With T1DM". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01939522. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*